SNP rs4646 of CYP19, located in the 3′ untranslated region, was recently found to be associated with circulating steroid hormone levels and with the objective response to the aromatase inhibitor letrozole in postmenopausal breast cancer [13, 14, 24]. This evidence concerns the gene CYP19A1 and breast carcinoma.